US FDA’s Cancer Drug/Diagnostic Pilot Program Aims To Close The Gap Between Regulation And Clinical Practice

 
• By Sue Sutter
  
Puzzle pieces
The FDA wants to narrow the space between regulation and clinical practice. • Source: Shutterstock

More from Approval Standards

More from Pathways & Standards